ELPA training

ELPA training

ELPA members participated in a highly impactful training session in Lisbon, where they engaged with representatives from Bayer and completed advanced clinical trial training focused on steatotic liver diseases (SLD). The event underscored the critical role of patient engagement in drug development and clinical research. The presentation by Bayer provided valuable insights into the latest advancements in liver health treatments and the importance of integrating patient perspectives in every phase of drug development. The small group of members who completed the clinical trial training are now better equipped to advocate for patient-centric approaches in designing and implementing trials. Both training highlights ELPA’s commitment to empowering patients to take an active role in shaping research priorities, ensuring that therapies align with patient needs and improve outcomes.